Travere Therapeutics, Inc. TVTX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s quick ratio?
- Travere Therapeutics, Inc. (TVTX) reported quick ratio of 2.9× in Q1 2026.
- How has Travere Therapeutics, Inc.'s quick ratio changed year-over-year?
- Travere Therapeutics, Inc.'s quick ratio increased by 54.8% year-over-year, from 1.9× to 2.9×.
- What is the long-term trend for Travere Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s quick ratio has grown at a -10.1% compound annual growth rate (CAGR), from 4.3× to 2.5×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.